<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36359844</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3448</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11213448</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease. Skeletal muscles and motor neurons (MNs) degenerate. ALS is a complex disease involving many genes in multiple tissues, the environment, cellular metabolism, and lifestyles. We hypothesized that epigenetic anomalies in DNA and RNA occur in ALS and examined this idea in: (1) mouse models of ALS, (2) human ALS, and (3) mouse ALS with therapeutic targeting of DNA methylation. Human superoxide dismutase-1 (hSOD1) transgenic (tg) mice were used. They expressed nonconditionally wildtype (WT) and the G93A and G37R mutant variants or skeletal muscle-restricted WT and G93A and G37R mutated forms. Age-matched non-tg mice were controls. hSOD1 mutant mice had increased DNA methyltransferase enzyme activity in spinal cord and skeletal muscle and increased 5-methylcytosine (5mC) levels. Genome-wide promoter CpG DNA methylation profiling in skeletal muscle of ALS mice identified hypermethylation notably in cytoskeletal genes. 5mC accumulated in spinal cord MNs and skeletal muscle satellite cells in mice. Significant increases in DNA methyltransferase-1 (DNMT1) and DNA methyltransferase-3A (DNMT3A) levels occurred in spinal cord nuclear and chromatin bound extracts of the different hSOD1 mouse lines. Mutant hSOD1 interacted with DNMT3A in skeletal muscle. 6-methyladenosine (6mA) RNA methylation was markedly increased or decreased in mouse spinal cord depending on hSOD1-G93A model, while fat mass and obesity associated protein was depleted and methyltransferase-like protein 3 was increased in spinal cord and skeletal muscle. Human ALS spinal cord had increased numbers of MNs and interneurons with nuclear 5mC, motor cortex had increased 5mC-positive neurons, while 6mA was severely depleted. Treatment of hSOD1-G93A mice with DNMT inhibitor improved motor function and extended lifespan by 25%. We conclude that DNA and RNA epigenetic anomalies are prominent in mouse and human ALS and are potentially targetable for disease-modifying therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Lee J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathobiology Graduate Training Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Danya A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedzwiecki</LastName><ForeName>Mark V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS34100</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D008780">Methyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>CLE6G00625</RegistryNumber><NameOfSubstance UI="C010223">N-methyladenosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008780" MajorTopicYN="Y">Methyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012323" MajorTopicYN="Y">RNA Processing, Post-Transcriptional</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">6-methyladenosine</Keyword><Keyword MajorTopicYN="N">CpG island</Keyword><Keyword MajorTopicYN="N">Dnmt3A</Keyword><Keyword MajorTopicYN="N">FTO</Keyword><Keyword MajorTopicYN="N">cytosine methylation</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36359844</ArticleId><ArticleId IdType="pmc">PMC9657572</ArticleId><ArticleId IdType="doi">10.3390/cells11213448</ArticleId><ArticleId IdType="pii">cells11213448</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:438&#x2013;458. doi: 10.1002/mus.10186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10186</ArticleId><ArticleId IdType="pubmed">12362409</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Jick S.S., Hern&#xe1;n M.A. Incidence and lifetime risk of motor neuron disease in the United Kingdom: A population-based study. Eur. J. Neurol. 2009;16:745&#x2013;751. doi: 10.1111/j.1468-1331.2009.02586.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02586.x</ArticleId><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. Effects of gender in amyotrophic lateral sclerosis. Gender Med. 2010;7:57&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J., Burgunder J.M. Recent progress in the genetics of motor neuron disease. Eur. J. Med. Genet. 2014;57:103&#x2013;112. doi: 10.1016/j.ejmg.2014.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2014.01.002</ArticleId><ArticleId IdType="pubmed">24503148</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Mitochondrial and cell death mechanisms in neurodegenerative disease. Pharmaceuticals. 2010;3:839&#x2013;915. doi: 10.3390/ph3040839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph3040839</ArticleId><ArticleId IdType="pmc">PMC3023298</ArticleId><ArticleId IdType="pubmed">21258649</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr I.S., McCann E.P., Benyamin B., Peters T.J., Twine N.A., Zhang K.Y., Zhao Q., Zhang Z.H., Rowe D.B., Nicholson G.A., et al. Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression. Sci. Rep. 2019;9:8254. doi: 10.1038/s41598-019-44765-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44765-4</ArticleId><ArticleId IdType="pmc">PMC6547746</ArticleId><ArticleId IdType="pubmed">31164693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolffe A.P., Matzke M.A. Epigenetics: Regulation through repression. Science. 1999;286:481&#x2013;486. doi: 10.1126/science.286.5439.481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5439.481</ArticleId><ArticleId IdType="pubmed">10521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaenisch R., Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet. 2003;33:245&#x2013;254. doi: 10.1038/ng1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1089</ArticleId><ArticleId IdType="pubmed">12610534</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner C., Fuks F. DNA methyltransferases: Facts, clues, mysteries. Curr. Top. Microbiol. Immunol. 2006;301:45&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">16570845</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6&#x2013;21. doi: 10.1101/gad.947102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.947102</ArticleId><ArticleId IdType="pubmed">11782440</ArticleId></ArticleIdList></Reference><Reference><Citation>Curradi M., Izzo A., Badaracco G., Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol. 2002;22:3157&#x2013;3173. doi: 10.1128/MCB.22.9.3157-3173.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.9.3157-3173.2002</ArticleId><ArticleId IdType="pmc">PMC133775</ArticleId><ArticleId IdType="pubmed">11940673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yan L., Davidson N. DNA methylation in breast cancer. Endocr. Relat. Cancer. 2001;8:115&#x2013;127. doi: 10.1677/erc.0.0080115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/erc.0.0080115</ArticleId><ArticleId IdType="pubmed">11446343</ArticleId></ArticleIdList></Reference><Reference><Citation>Luczak M.W., Jagodzinski P.P. The role of DNA methylation in cancer development. Folia Histochem. Cytobiol. 2006;44:43&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">16977793</ArticleId></ArticleIdList></Reference><Reference><Citation>Levenson J.M., Roth T.L., Lubin F.D., Miller C.A., Huang I.C., Desai P., Malone L.M., Sweatt J.D. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 2006;281:5763&#x2013;15773. doi: 10.1074/jbc.M511767200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M511767200</ArticleId><ArticleId IdType="pubmed">16606618</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: A new target of disease mechanisms. Neurotherapeutics. 2013;10:722&#x2013;733. doi: 10.1007/s13311-013-0205-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0205-6</ArticleId><ArticleId IdType="pmc">PMC3805862</ArticleId><ArticleId IdType="pubmed">23900692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.W., Jeong Y.E., Wong M., Martin L.J. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathol. Commun. 2020;8:1&#x2013;26. doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X. Structure and function of DNA methyltransferases. Annu. Rev. Biophys. Biomol. Struct. 1995;24:293&#x2013;318. doi: 10.1146/annurev.bb.24.060195.001453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bb.24.060195.001453</ArticleId><ArticleId IdType="pubmed">7663118</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan S., Bacolla A., Wells R.D., Roberts R.J. Recombinant human DNA (cytosine-5) methyltransferase. I. expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 1999;274:33002&#x2013;33010. doi: 10.1074/jbc.274.46.33002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.46.33002</ArticleId><ArticleId IdType="pubmed">10551868</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000;9:2395&#x2013;2402. doi: 10.1093/hmg/9.16.2395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.16.2395</ArticleId><ArticleId IdType="pubmed">11005794</ArticleId></ArticleIdList></Reference><Reference><Citation>Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry. 2005;70:533&#x2013;549. doi: 10.1007/s10541-005-0147-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10541-005-0147-7</ArticleId><ArticleId IdType="pubmed">15948707</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson K.D. DNA methylation, methyltransferases, and cancer. Oncogene. 2002;20:3139&#x2013;3155. doi: 10.1038/sj.onc.1204341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1204341</ArticleId><ArticleId IdType="pubmed">11420731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortusewicz O., Schermelleh L., Walter J., Cardoso M.C., Leonhardt H. Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl. Acad. Sci. USA. 2005;102:8905&#x2013;8909. doi: 10.1073/pnas.0501034102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501034102</ArticleId><ArticleId IdType="pmc">PMC1157029</ArticleId><ArticleId IdType="pubmed">15956212</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C.J., Botuyan M.-V., Wu Y., Ward C.J., Nicholson G.A., Hammans S., Hojo K., Yamanishi H., Karpf A.R., Wallace D.C., et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat. Genet. 2011;43:595&#x2013;600. doi: 10.1038/ng.830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.830</ArticleId><ArticleId IdType="pmc">PMC3102765</ArticleId><ArticleId IdType="pubmed">21532572</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelman J., Lin L., Schormair B., Kornum B.R., Faraco J., Plazzi G., Melberg A., Cornelio F., Urban A.E., Pizza F., et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum. Mol. Genet. 2012;21:2205&#x2013;2210. doi: 10.1093/hmg/dds035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds035</ArticleId><ArticleId IdType="pmc">PMC3465691</ArticleId><ArticleId IdType="pubmed">22328086</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247&#x2013;257. doi: 10.1016/S0092-8674(00)81656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81656-6</ArticleId><ArticleId IdType="pubmed">10555141</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie S., Wang Z., Okano M., Nogami M., Li Y., He W.W., Okumura K., Li E. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene. 1999;236:87&#x2013;95. doi: 10.1016/S0378-1119(99)00252-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(99)00252-8</ArticleId><ArticleId IdType="pubmed">10433969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic regulation of motor neuron cell death through DNA methylation. J. Neurosci. 2011;31:16619&#x2013;16636. doi: 10.1523/JNEUROSCI.1639-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1639-11.2011</ArticleId><ArticleId IdType="pmc">PMC3238138</ArticleId><ArticleId IdType="pubmed">22090490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Gertz B., Chestnut B.A., Martin L.J. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front. Cell. Neurosci. 2013;7:279. doi: 10.3389/fncel.2013.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00279</ArticleId><ArticleId IdType="pmc">PMC3872319</ArticleId><ArticleId IdType="pubmed">24399935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatton-Brown K., Seal S., Ruark E., Harmer J., Ramsay E., Del Vecchio Duarte S., Zachariou A., Hanks S., O&#x2019;Brien E., Aksglaede L., et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 2014;46:385&#x2013;388. doi: 10.1038/ng.2917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2917</ArticleId><ArticleId IdType="pmc">PMC3981653</ArticleId><ArticleId IdType="pubmed">24614070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock L.S., Thakkar P.V., Peterson E.J., Moran R.G., Taylor S.M. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc. Natl. Acad. Sci. USA. 2011;108:3630&#x2013;3635. doi: 10.1073/pnas.1012311108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012311108</ArticleId><ArticleId IdType="pmc">PMC3048134</ArticleId><ArticleId IdType="pubmed">21321201</ArticleId></ArticleIdList></Reference><Reference><Citation>He C. RNA epigenetics? Nat. Chem. Biol. 2010;6:863&#x2013;865. doi: 10.1038/nchembio.482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.482</ArticleId><ArticleId IdType="pubmed">21079590</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell R.B., Ke S., Darnell J.E., Jr. Pre-mRNA processing includes N6 methylation of adenosine residues that are retained in mRNA exons and the fallacy of &#x201c;RNA epigenetics&#x201d;. RNA. 2018;24:262&#x2013;267. doi: 10.1261/rna.065219.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.065219.117</ArticleId><ArticleId IdType="pmc">PMC5824346</ArticleId><ArticleId IdType="pubmed">29222117</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer M., Lyko. F. Solving the Dnmt2 enigma. Chromosoma. 2010;119:35&#x2013;40. doi: 10.1007/s00412-009-0240-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-009-0240-6</ArticleId><ArticleId IdType="pubmed">19730874</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H., Tang H.F., Kai Y. N6-methyladenine RNA modification (m6A): An emerging regulator of metabolic diseases. Curr. Drug Targets. 2020;21:1056&#x2013;1067. doi: 10.2174/1389450121666200210125247.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450121666200210125247</ArticleId><ArticleId IdType="pubmed">32066359</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Weng H., Chen J. The biogenesis and precise control of RNA m6A methylation. Trends Genet. 2020;36:44&#x2013;52. doi: 10.1016/j.tig.2019.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.10.011</ArticleId><ArticleId IdType="pmc">PMC6925345</ArticleId><ArticleId IdType="pubmed">31810533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Ding C., Zuo Y., Peng Y., Zuo L. N6-methyladenosine and neurological diseases. Mol. Neurobiol. 2022;59:1925&#x2013;1937. doi: 10.1007/s12035-022-02739-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02739-0</ArticleId><ArticleId IdType="pubmed">35032318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer M., Pollex T., Hanna K., Tuorto F., Meusburger M., Helm M., Lykom F. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev. 2010;24:1590&#x2013;1595. doi: 10.1101/gad.586710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.586710</ArticleId><ArticleId IdType="pmc">PMC2912555</ArticleId><ArticleId IdType="pubmed">20679393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuorto F., Liebers R., Musch T., Schaefer M., Hofmann S., Kellner S., Frye M., Helm M., Stoecklin G., Lyko F. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat. Struct. Mol. Biol. 2012;19:900&#x2013;905. doi: 10.1038/nsmb.2357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2357</ArticleId><ArticleId IdType="pubmed">22885326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke S., Pandya-Jones A., Saito Y., Fak J.J., V&#xe5;gb&#xf8; C.B., Geula S., Hanna J.H., Black D.L., Darnell J.E., Jr., Darnell R.B. m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Genes Dev. 2017;31:990&#x2013;1006. doi: 10.1101/gad.301036.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.301036.117</ArticleId><ArticleId IdType="pmc">PMC5495127</ArticleId><ArticleId IdType="pubmed">28637692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hop P.J., Zwamborn R.A.J., Hannon E., Shireby G.L., Nabais M.F., Walker E.M., van Rheenen W., van Vugt J.J.F.A., Dekker A.M., Westeneng H.J., et al. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Sci. Transl. Med. 2022;14:eabj0264. doi: 10.1126/scitranslmed.abj0264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj0264</ArticleId><ArticleId IdType="pubmed">35196023</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccaficao S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome. Front. Neurol. 2020;11:592851. doi: 10.3389/fneur.2020.592851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592851</ArticleId><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikatza-Menoio O., Elicegui A., Bengoetxea X., Naldaiz-Gastesi N., L&#xf3;pez de Munain A., Gerenu G., Gil-Bea F.J., Alonso-Mart&#xed;n S. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis. J. Pers. Med. 2021;11:671. doi: 10.3390/jpm11070671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070671</ArticleId><ArticleId IdType="pmc">PMC8307751</ArticleId><ArticleId IdType="pubmed">34357138</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Ioannides Z.A., van Eijk R.P.A., Heggie S., Thorpe K.A., Ceslis A., Heshmat S., Henders A.K., Wray N.R., van den Berg L.H., et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., Gonzalez de Aguilar J.L., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Petersen A., Wedt P. Thermoregulation in amyotrophic lateral sclerosis. In: Romanovsky A.A., editor. Thermoregulation: From Basic Neuroscience to Clinical Neurology. Volume 157. Elsevier; Amsterdam, The Netherlands: 2018. pp. 749&#x2013;760. Part II.</Citation><ArticleIdList><ArticleId IdType="pubmed">30459038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M.A., Yates P.O. Motor neurone disease: The nature of the pathogenic mechanism. J. Neurol. Neurosurg. Psychiatry. 1974;37:1036&#x2013;1046. doi: 10.1136/jnnp.37.9.1036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.37.9.1036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H.A., McMahon S., Sun D.Y., Abbs J.H., Uemura E. Neuronal RNA in nucleus ambiguus and nucleus hypoglossus of patients with amyotrophic lateral sclerosis. J. Neuropath. Exp. Neurol. 1989;48:669&#x2013;673. doi: 10.1097/00005072-198911000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198911000-00008</ArticleId><ArticleId IdType="pubmed">2477507</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson T.J., Hartmann H.A., Johnson P.C. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. I. The cervical swelling. J. Neuropathol. Exp. Neurol. 1981;40:32&#x2013;36. doi: 10.1097/00005072-198101000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198101000-00004</ArticleId><ArticleId IdType="pubmed">6162920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H.A., Sun D.Y. Regional mRNA changes in brain stem motor neurons from patients with amyotrophic lateral sclerosis. Mol. Chem. Neuropath. 1992;17:249&#x2013;257. doi: 10.1007/BF03160014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03160014</ArticleId><ArticleId IdType="pubmed">1492883</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Liu Z., Chen K., Price A.C., Pan Y., Swaby J.A., Golden W.C. Motor neuron degeneration in ALS mutant superoxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 2007;500:20&#x2013;46. doi: 10.1002/cne.21160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21160</ArticleId><ArticleId IdType="pubmed">17099894</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., Chang Q. The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice. Exp. Neurol. 2009;218:333&#x2013;346. doi: 10.1016/j.expneurol.2009.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.02.015</ArticleId><ArticleId IdType="pmc">PMC2710399</ArticleId><ArticleId IdType="pubmed">19272377</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Fancelli D., Wong M., Niedzwiecki M., Ballarini M., Plyte S., Chang Q. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:433. doi: 10.3389/fncel.2014.00433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00433</ArticleId><ArticleId IdType="pmc">PMC4271619</ArticleId><ArticleId IdType="pubmed">25565966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gertz B., Wong M., Martin L.J. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J. Neuropathol. Exp. Neurol. 2012;71:162&#x2013;177. doi: 10.1097/NEN.0b013e318244b635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318244b635</ArticleId><ArticleId IdType="pmc">PMC3432922</ArticleId><ArticleId IdType="pubmed">22249462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Northington F.J., Martin L.J. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 2010;214:219&#x2013;234. doi: 10.1007/s00429-009-0226-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-009-0226-4</ArticleId><ArticleId IdType="pmc">PMC3010349</ArticleId><ArticleId IdType="pubmed">19888600</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerc P., Lipnick S., Willett C. A look into the future if ALS research. Drug Discov. Today. 2016;21:939949. doi: 10.1016/j.drudis.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2016.02.002</ArticleId><ArticleId IdType="pubmed">26861067</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Haasdijk E.D., Grashorn J.A., Hawkins R., van Duijn W., Verspaget H.W., London J., Holstege J.C. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 2000;7:623&#x2013;643. doi: 10.1006/nbdi.2000.0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 1999;58:459&#x2013;471. doi: 10.1097/00005072-199905000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199905000-00005</ArticleId><ArticleId IdType="pubmed">10331434</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 2000;7:613&#x2013;622. doi: 10.1006/nbdi.2000.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0314</ArticleId><ArticleId IdType="pubmed">11114260</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh A.Y., Martin L.J. DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis. Neuromolecular. Med. 2002;2:47&#x2013;60. doi: 10.1007/s12017-002-0038-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-002-0038-7</ArticleId><ArticleId IdType="pubmed">12230304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayzullina S., Martin L.J. DNA damage response and DNA repair in skeletal myocytes from a mouse model of spinal muscular atrophy. J. Neuropathol. Exp. Neurol. 2016;75:889&#x2013;902. doi: 10.1093/jnen/nlw064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlw064</ArticleId><ArticleId IdType="pmc">PMC5015659</ArticleId><ArticleId IdType="pubmed">27452406</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Blackstone C.D., Huganir R.L., Price D.L. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron. 1992;9:259&#x2013;270. doi: 10.1016/0896-6273(92)90165-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90165-A</ArticleId><ArticleId IdType="pubmed">1323311</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta A., Martin L.J. Laminar segregation of the cortical plate during corticogenesis is accompanied by changes in glutamate receptor expression. J. Neurobiol. 1999;39:67&#x2013;80. doi: 10.1002/(SICI)1097-4695(199904)39:1&lt;67::AID-NEU6&gt;3.0.CO;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(199904)39:1&lt;67::AID-NEU6&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">10213454</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta A., Price D.L., Pardo C.A., Troncoso J.C., Xu Z.S., Taniguchi N., Martin L.J. Localization of superoxide dismutases in Alzheimer&#x2019;s disease and Down&#x2019;s syndrome neocortex and hippocampus. Am. J. Pathol. 1995;146:357&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1869844</ArticleId><ArticleId IdType="pubmed">7856748</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Pardo C.A., Cork L.C., Price D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 1994;145:1358&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887492</ArticleId><ArticleId IdType="pubmed">7992840</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Price A.C., McClendon K.B., Al-Abdulla N.A., Subramaniam J.R., Wong P.C., Liu Z. Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: Oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. J. Neurochem. 2003;85:234&#x2013;247. doi: 10.1046/j.1471-4159.2003.01659.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01659.x</ArticleId><ArticleId IdType="pubmed">12641745</ArticleId></ArticleIdList></Reference><Reference><Citation>Siedlecki P., Garcia Boy R., Much T., Brueckner B., Suhai S., Lyko F., Zielenkiewicz P. Discovery of two novel, small-molecule inhibitors of DNA methylation. J. Med. Chem. 2006;49:678&#x2013;683. doi: 10.1021/jm050844z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm050844z</ArticleId><ArticleId IdType="pubmed">16420053</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T., Tanaka R., Hamada S., Nakagawa H., Miyata N. Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors. Bioorg. Med. Chem. Lett. 2010;20:1124&#x2013;1127. doi: 10.1016/j.bmcl.2009.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2009.12.016</ArticleId><ArticleId IdType="pubmed">20056538</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M., Hellmann I., Stadler M., Ramos L., Paabo S., Rebhan M., Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 2007;39:457&#x2013;466. doi: 10.1038/ng1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1990</ArticleId><ArticleId IdType="pubmed">17334365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q., Martin L.J. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: A quantitative confocal analysis. Am. J. Pathol. 2009;174:574&#x2013;585. doi: 10.2353/ajpath.2009.080557.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.080557</ArticleId><ArticleId IdType="pmc">PMC2630565</ArticleId><ArticleId IdType="pubmed">19116365</ArticleId></ArticleIdList></Reference><Reference><Citation>McTaggart J.S., Lee S., Iberl M., Church C., Cox R.D., Ashcroft F.M. FTO is expressed in neurones throughout the brain and its expression is unaltered by fasting. PLoS ONE. 2011;6:e27968. doi: 10.1371/journal.pone.0027968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027968</ArticleId><ArticleId IdType="pmc">PMC3227617</ArticleId><ArticleId IdType="pubmed">22140494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Hu J., Sun X., Yang K., Yang L., Kong L., Zhang B., Li F., Li C., Shi B., et al. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin. Transl. Med. 2021;11:e402. doi: 10.1002/ctm2.402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.402</ArticleId><ArticleId IdType="pmc">PMC8087997</ArticleId><ArticleId IdType="pubmed">34047466</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Hou G., Zhang H., Dou J., He J., Guo Y., Li L., Chen R., Wang Y., Deng R., et al. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. Nucleic Acids Res. 2018;46:5195&#x2013;5208. doi: 10.1093/nar/gky156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky156</ArticleId><ArticleId IdType="pmc">PMC6007514</ArticleId><ArticleId IdType="pubmed">29506078</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhou T., Wang Q., Fu R., Zhang Z., Chen N., Li Z., Gao G., Peng S., Yang D. m6A demethylase ALKBH5 drives denervation-induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling. J. Cachexia Sarcopenia Muscle. 2022;13:1210&#x2013;1223. doi: 10.1002/jcsm.12929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12929</ArticleId><ArticleId IdType="pmc">PMC8978003</ArticleId><ArticleId IdType="pubmed">35142084</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:3156. doi: 10.1186/gb-2013-14-10-r115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2013-14-10-r115</ArticleId><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S., Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 2018;19:371&#x2013;384. doi: 10.1038/s41576-018-0004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0004-3</ArticleId><ArticleId IdType="pubmed">29643443</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M.E., Lu A.T., Quach A., Chen B.H., Assimes T.L., Bandinelli S., Hou L., Baccarelli A.A., Stewart J.D., Li Y., et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;1810:573&#x2013;591. doi: 10.18632/aging.101414.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101414</ArticleId><ArticleId IdType="pmc">PMC5940111</ArticleId><ArticleId IdType="pubmed">29676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender P., Ghai M., Okpeku M. Sex-specific DNA methylation: Impact on human health and development. Mol. Genet. Genom. 2022;297:1451&#x2013;1466. doi: 10.1007/s00438-022-01935-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-022-01935-w</ArticleId><ArticleId IdType="pubmed">35969270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Tartaglia M.C., Moreno D., Sato C., McKeever P., Weichert A., Keith J., Robertson J., Zinman L., Rogaeva E. DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients. Acta Neuropathol. 2017;134:271&#x2013;279. doi: 10.1007/s00401-017-1713-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1713-y</ArticleId><ArticleId IdType="pmc">PMC5508035</ArticleId><ArticleId IdType="pubmed">28439722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., McKeever P.M., Xi Z., Moreno D., Sato C., Bergsma T., McGoldrick P., Keith J., Robertson J., Zinman L., et al. DNA methylation age acceleration is associated with ALS age of onset and survival. Acta Neuropathol. 2020;139:943&#x2013;946. doi: 10.1007/s00401-020-02131-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02131-z</ArticleId><ArticleId IdType="pmc">PMC7181538</ArticleId><ArticleId IdType="pubmed">32146547</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliore L., Copped&#xe8; F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 2009;667:82&#x2013;97. doi: 10.1016/j.mrfmmm.2008.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2008.10.011</ArticleId><ArticleId IdType="pubmed">19026668</ArticleId></ArticleIdList></Reference><Reference><Citation>Freydenzon A., Nabais M.F., Lin T., Williams K.L., Wallace L., Henders A.K., Blair I.P., Wray N.R., Pamphlett R., McRae A.E. Association between DNA methylation variability and self-reported exposure to heavy metals. Sci. Rep. 2022;12:10582. doi: 10.1038/s41598-022-13892-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13892-w</ArticleId><ArticleId IdType="pmc">PMC9217962</ArticleId><ArticleId IdType="pubmed">35732753</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Benzi G., Dossena M., Mutani R., Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Bianchi E., Vanacore N., Montalto C., Ricca G., Della Cuna R.S., Fumagalli F., Castellani M., Poli F., Romeo F., et al. Increased risk and early onset of ALS in professional players from Italian soccer teams. Amyotrop. Lateral Scler. Frontotemporal Degener. 2020;21:403&#x2013;409. doi: 10.1080/21678421.2020.1752250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1752250</ArticleId><ArticleId IdType="pubmed">32321311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Barbiera A., Sica G., Scicchitano B.M. Age-related alterations at neuromuscular junction: Role of oxidative stress and epigenetic modifications. Cells. 2021;10:1307. doi: 10.3390/cells10061307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061307</ArticleId><ArticleId IdType="pmc">PMC8225025</ArticleId><ArticleId IdType="pubmed">34074012</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates N., Pamphlett R. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler. 2007;8:3&#x2013;86. doi: 10.1080/17482960601149160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960601149160</ArticleId><ArticleId IdType="pubmed">17453634</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan J.M., Yu B., Trent R.J., Pamphlett R. Are metallothionein genes silenced in ALS? Toxicol. Lett. 2007;168:83&#x2013;87. doi: 10.1016/j.toxlet.2006.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2006.11.003</ArticleId><ArticleId IdType="pubmed">17156946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Gozen O., Vidensky S., Robinson M.B., Rothstein J.D. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia. 2010;58:277&#x2013;286. doi: 10.1002/glia.20922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20922</ArticleId><ArticleId IdType="pmc">PMC2794958</ArticleId><ArticleId IdType="pubmed">19672971</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan J.M., Yu B., Trent R.J., Pamphlett R. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:418&#x2013;429. doi: 10.3109/17482960802635397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802635397</ArticleId><ArticleId IdType="pubmed">19922134</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Majchrzak-Celi&#x144;ska A., Warych A., Szoszkiewicz M. Novel approaches to epigenetic therapies: From drug combinations to epigenetic editing. Genes. 2021;12:208. doi: 10.3390/genes12020208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12020208</ArticleId><ArticleId IdType="pmc">PMC7911730</ArticleId><ArticleId IdType="pubmed">33572577</ArticleId></ArticleIdList></Reference><Reference><Citation>Price D.L., Porter K.R. The response of ventral horn neurons to axonal transection. J. Cell Biol. 1972;53:24&#x2013;37. doi: 10.1083/jcb.53.1.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.53.1.24</ArticleId><ArticleId IdType="pmc">PMC2108703</ArticleId><ArticleId IdType="pubmed">4111146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Lagas S., Roy A., Kumar H. Cytoskeleton saga: Its regulation in normal physiology and modulation in neurodegenerative disorders. Eur. J. Pharm. 2022;925:175001. doi: 10.1016/j.ejphar.2022.175001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.175001</ArticleId><ArticleId IdType="pubmed">35525310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Cudkowicz M.E., Hardiman O., Cockroft B.M., Lee J.H., Malik F.I., Meng L., Rudnicki S.A., Wolff A.A., Andrews J.A., et al. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Front. Degener. 2019;20:584&#x2013;594. doi: 10.1080/21678421.2019.1612922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1612922</ArticleId><ArticleId IdType="pubmed">31081694</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J.P., Brotto M.A., Hossain M.M., Huang Q.Q., Brotto L.S., Nosek T.M., Morton D.H., Crawford T.O. Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. J. Biol. Chem. 2003;278:26159&#x2013;26165. doi: 10.1074/jbc.M303469200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303469200</ArticleId><ArticleId IdType="pubmed">12732643</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksin-Matveev A., Kanfi Y., Hochhauser E., Isak A., Cohen H.Y., Shainberg A. Sirtuin 6 protects the heart from hypoxic damage. Exp. Cell Res. 2015;330:81&#x2013;90. doi: 10.1016/j.yexcr.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2014.07.013</ArticleId><ArticleId IdType="pubmed">25066211</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X., Yao L., Yang X., Gao Y., Fang F., Zhang J., Wang Q., Chang Y. SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK. Am. J. Physiol. Endocrinol. Metab. 2017;313:E493&#x2013;E505. doi: 10.1152/ajpendo.00122.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00122.2017</ArticleId><ArticleId IdType="pubmed">28765271</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L., Cui X., Chen Q., Yang X., Fang F., Zhang J., Liu G., Jin W., Chang Y. Cold-inducible SIRT6 regulates thermogenesis of brown and beige fat. Cell Rep. 2017;20:641&#x2013;654. doi: 10.1016/j.celrep.2017.06.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.06.069</ArticleId><ArticleId IdType="pubmed">28723567</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Niedzwiecki M.V., Wong M. Chronic intermittent mild whole-body hypothermia is therapeutic in a mouse model of ALS. Cells. 2021;10:320. doi: 10.3390/cells10020320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020320</ArticleId><ArticleId IdType="pmc">PMC7913914</ArticleId><ArticleId IdType="pubmed">33557211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Chen X., Cai X., Lin H., Xu J., Cheng X. RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA. Cell Death Discov. 2022;8:250. doi: 10.1038/s41420-022-01049-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-022-01049-7</ArticleId><ArticleId IdType="pmc">PMC9072549</ArticleId><ArticleId IdType="pubmed">35513372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Zhang P., Liu Z., Xing Y., Xiao Y. NXPH4 promotes gemcitabine resistance in bladder cancer by enhancing reactive oxygen species and glycolysis activation through modulating NDUFA4L2. Cancers. 2022;14:3782. doi: 10.3390/cancers14153782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14153782</ArticleId><ArticleId IdType="pmc">PMC9367313</ArticleId><ArticleId IdType="pubmed">35954445</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet M., Vargas C., Larrieu D., Torrisani J., Dufresne M. E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions. Int. J. Mol. Sci. 2020;21:8515. doi: 10.3390/ijms21228515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228515</ArticleId><ArticleId IdType="pmc">PMC7697007</ArticleId><ArticleId IdType="pubmed">33198194</ArticleId></ArticleIdList></Reference><Reference><Citation>An C.I., Ganio E., Hagiwara N. Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells. Skeletal Muscle. 2013;3:11. doi: 10.1186/2044-5040-3-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-3-11</ArticleId><ArticleId IdType="pmc">PMC3666947</ArticleId><ArticleId IdType="pubmed">23663701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangari S., Peyre I., Lackmy-Vall&#xe9;e A., Bayen E., Pradat P.-F., Marchand-Pauvert V. Transient increase in recurrent inhibition in amyotrophic lateral sclerosis as a putative protection from neurodegeneration. Acta Physiol. 2022;234:e13758. doi: 10.1111/apha.13758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13758</ArticleId><ArticleId IdType="pubmed">34981890</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K., Ikuta F., Horikawa Y. Evidence for sequential degeneration of the neurons in the intermediate zone of the spinal cord in amyotrophic lateral sclerosis: A topographic and quantitative investigation. Acta Neuropathol. 1989;77:343&#x2013;349. doi: 10.1007/BF00687368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00687368</ArticleId><ArticleId IdType="pubmed">2711828</ArticleId></ArticleIdList></Reference><Reference><Citation>Brueckner B., Garcia Boy R., Siedlecki P., Much T., Kliem H.C., Zielenkiewicz P., Suhai S., Wiessler M., Lyko F. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res. 2005;65:6305&#x2013;6311. doi: 10.1158/0008-5472.CAN-04-2957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-2957</ArticleId><ArticleId IdType="pubmed">16024632</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh Y.S., Kim S.H., Cho G.W. Functional restoration of amyotrophic lateral sclerosis patient-derived mesenchymal stromal cells through inhibition of DNA methyltransferase. Cell. Mol. Neurobiol. 2016;36:613&#x2013;620. doi: 10.1007/s10571-015-0242-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0242-2</ArticleId><ArticleId IdType="pubmed">26210997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo N., Tohnai G., Sahashi K., Iida M., Kataoka M., Nakatsuji H., Tsutsumi Y., Hashizume A., Adachi H., Koike H., et al. DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5. EMBO Mol. Med. 2019;11:e8547. doi: 10.15252/emmm.201708547.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708547</ArticleId><ArticleId IdType="pmc">PMC6505579</ArticleId><ArticleId IdType="pubmed">30940675</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Kaiser A., Price A.C. Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J. Neurobiol. 1999;40:185&#x2013;201. doi: 10.1002/(SICI)1097-4695(199908)40:2&lt;185::AID-NEU5&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(199908)40:2&lt;185::AID-NEU5&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">10413449</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Liu Z. Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53- and bax-dependent. J. Neurobiol. 2002;50:181&#x2013;197. doi: 10.1002/neu.10026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.10026</ArticleId><ArticleId IdType="pubmed">11810634</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Chen K., Liu Z. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J. Neurosci. 2005;25:6449&#x2013;6459. doi: 10.1523/JNEUROSCI.0911-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0911-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725285</ArticleId><ArticleId IdType="pubmed">16000635</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook A.M., Mieure K.D., Owen R.D., Pesaturo A.B., Hatton J. Intracerebroventricular administration of drugs. Pharmacotherapy. 2009;29:832&#x2013;845. doi: 10.1592/phco.29.7.832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1592/phco.29.7.832</ArticleId><ArticleId IdType="pubmed">19558257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarda N., Reynaud D., Gharib A. S-adenosylmethionine, S-adenosylhomocysteine and adenosine system. Age-dependent availability in rat brain. Dev. Pharmacol. Ther. 1989;13:104&#x2013;112. doi: 10.1159/000457591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000457591</ArticleId><ArticleId IdType="pubmed">2612296</ArticleId></ArticleIdList></Reference><Reference><Citation>Stramentinoli G., Gualano M., Catto E., Algeri S. Tissue levels of S-adenosylmethionine in aging rats. J. Gerontol. 1977;32:392&#x2013;394. doi: 10.1093/geronj/32.4.392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/32.4.392</ArticleId><ArticleId IdType="pubmed">864203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharib A., Sarda N., Chabannes B., Cronenberger L., Pacheco H. The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. J. Neurochem. 1982;38:810&#x2013;815. doi: 10.1111/j.1471-4159.1982.tb08702.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1982.tb08702.x</ArticleId><ArticleId IdType="pubmed">7057194</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson T.J., Hartmann H.A. Base composition of RNA obtained from motor neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1981;40:193&#x2013;198. doi: 10.1097/00005072-198103000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198103000-00010</ArticleId><ArticleId IdType="pubmed">6162011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>